Gene-Modified Human α/β-T Cells Expressing a Chimeric CD16-CD3ζ Receptor as Adoptively Transferable Effector Cells for Anticancer Monoclonal Antibody TherapyFumihiro Ochi, Masaki Yasukawa|Cancer Immunology Research|2014Cited by 47